(HealthDay)—Combined inhibition of tumor necrosis factor (TNF) ? and interleukin (IL)-17 is more effective than single blockade in cultures of human fibroblast-like synoviocytes (FLS), according to an experimental study published in the January issue of Arthritis Rheumatology.
Jens A.A. F…
Combined inhibition of TNF-alpha, IL-17 effective in RA model
Health News 